Biopharma facing two major crises - a huge patent cliff and price controls

Forbes

26 June 2023 - The recent productivity of the biopharmaceutical industry has been truly remarkable. From 2017 – 2022, 287 new medicines were approved including drugs to treat a variety of cancers, rare diseases, diabetes, obesity and even Alzheimer’s disease. 

And, if that wasn’t enough, this industry gave us Covid-19 vaccines and therapeutants that enabled us to get past the worst pandemic in 100 years. All of these achievements have benefitted billions of people around the world.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder